Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Alexander Goldfarb-Rumyantzev, Ph.D., M.D.

TitleAssistant Clinical Professor of Medicine
InstitutionBeth Israel Deaconess Medical Center
DepartmentMedicine
AddressBeth Israel Deaconess Medical Center
E/da 517
185 Pilgrim Road
Boston MA 02215
Phone617/632-9880
Fax617/667-5276

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Rogers CC, Asipenko N, Horwedel T, Gautam S, Goldfarb-Rumyantzev AS, Pavlakis M, Johnson SR, Karp SJ, Evenson A, Khwaja K, Hanto DW, Mandelbrot DA. Renal transplantation in the setting of early steroid withdrawal: a comparison of rabbit antithymocyte globulin induction dosing in two eras. Am J Nephrol. 2013; 38(5):397-404.
    View in: PubMed
  2. Patibandla BK, Narra A, Desilva R, Chawla V, Vin Y, Brown RS, Goldfarb-Rumyantzev AS. Disparities in arteriovenous fistula placement in older hemodialysis patients. Hemodial Int. 2014 Jan; 18(1):118-26.
    View in: PubMed
  3. Sandhu GS, Khattak M, Pavlakis M, Woodward R, Hanto DW, Wasilewski MA, Dimitri N, Goldfarb-Rumyantzev A. Recipient's unemployment restricts access to renal transplantation. Clin Transplant. 2013 Jul; 27(4):598-606.
    View in: PubMed
  4. Desilva RN, Patibandla BK, Vin Y, Narra A, Chawla V, Brown RS, Goldfarb-Rumyantzev AS. Fistula first is not always the best strategy for the elderly. J Am Soc Nephrol. 2013 Jul; 24(8):1297-304.
    View in: PubMed
  5. Goldfarb-Rumyantzev AS, Yoon JH, Patibandla BK, Narra A, Sandhu GS, Desilva R. The role of initial hemodialysis vascular access in the outcome of subsequent kidney transplantation. Clin Transplant. 2013 Mar; 27(2):210-6.
    View in: PubMed
  6. Goldfarb-Rumyantzev AS, Sandhu GS, Barenbaum A, Baird BC, Patibandla BK, Narra A, Koford JK, Barenbaum L. Education is associated with reduction in racial disparities in kidney transplant outcome. Clin Transplant. 2012 Nov; 26(6):891-9.
    View in: PubMed
  7. Patibandla BK, Narra A, DeSilva R, Chawla V, Goldfarb-Rumyantzev AS. Access to renal transplantation in the diabetic population-effect of comorbidities and body mass index. Clin Transplant. 2012 May-Jun; 26(3):E307-15.
    View in: PubMed
  8. DeSilva RN, Sandhu GS, Garg J, Goldfarb-Rumyantzev AS. Association between initial type of hemodialysis access used in the elderly and mortality. Hemodial Int. 2012 Apr; 16(2):233-41.
    View in: PubMed
  9. Goldfarb-Rumyantzev AS, Rout P, Sandhu GS, Barenbaum A, Patibandla BK, Narra A, Chawla V, Williams M. Social adaptability index predicts overall mortality in patients with diabetes. J Diabetes Complications. 2012 Jan-Feb; 26(1):44-9.
    View in: PubMed
  10. Khattak M, Sandhu GS, Desilva R, Goldfarb-Rumyantzev AS. Association of education level with dialysis outcome. Hemodial Int. 2012 Jan; 16(1):82-8.
    View in: PubMed
  11. Garg J, Karim M, Tang H, Sandhu GS, DeSilva R, Rodrigue JR, Pavlakis M, Hanto DW, Baird BC, Goldfarb-Rumyantzev AS. Social adaptability index predicts kidney transplant outcome: a single-center retrospective analysis. Nephrol Dial Transplant. 2012 Mar; 27(3):1239-45.
    View in: PubMed
  12. Goldfarb-Rumyantzev A, Barenbaum A, Rodrigue J, Rout P, Isaacs R, Mukamal K. New social adaptability index predicts overall mortality. Arch Med Sci. 2011 Aug; 7(4):720-7.
    View in: PubMed
  13. Tang H, Poynton MR, Hurdle JF, Baird BC, Koford JK, Goldfarb-Rumyantzev AS. Predicting three-year kidney graft survival in recipients with systemic lupus erythematosus. ASAIO J. 2011 Jul-Aug; 57(4):300-9.
    View in: PubMed
  14. Tang H, Hurdle JF, Poynton M, Hunter C, Tu M, Baird BC, Krikov S, Goldfarb-Rumyantzev AS. Validating prediction models of kidney transplant outcome using single center data. ASAIO J. 2011 May-Jun; 57(3):206-12.
    View in: PubMed
  15. Goldfarb-Rumyantzev AS, Sandhu GS, Baird BC, Khattak M, Barenbaum A, Hanto DW. Social Adaptability Index predicts access to kidney transplantation. Clin Transplant. 2011 Nov-Dec; 25(6):834-42.
    View in: PubMed
  16. Sandhu GS, Khattak M, Rout P, Williams ME, Gautam S, Baird B, Goldfarb-Rumyantzev AS. Social Adaptability Index: application and outcomes in a dialysis population. Nephrol Dial Transplant. 2011 Aug; 26(8):2667-74.
    View in: PubMed
  17. Sandhu GS, Khattak M, Woodward RS, Hanto DW, Pavlakis M, Dimitri N, Goldfarb-Rumyantzev AS. Impact of substance abuse on access to renal transplantation. Transplantation. 2011 Jan 15; 91(1):86-93.
    View in: PubMed
  18. Goldfarb-Rumyantzev AS, Sandhu GS, Baird B, Barenbaum A, Yoon JH, Dimitri N, Koford JK, Shihab F. Effect of education on racial disparities in access to kidney transplantation. Clin Transplant. 2012 Jan-Feb; 26(1):74-81.
    View in: PubMed
  19. Khattak MW, Sandhu GS, Woodward R, Stoff JS, Goldfarb-Rumyantzev AS. Association of marital status with access to renal transplantation. Am J Transplant. 2010 Dec; 10(12):2624-31.
    View in: PubMed
  20. Goldfarb-Rumyantzev AS. Personalized medicine and prediction of outcome in kidney transplant. Am J Kidney Dis. 2010 Nov; 56(5):817-9.
    View in: PubMed
  21. Goldfarb-Rumyantzev AS, Wright S, Ragasa R, Ostler D, Van Orden J, Smith L, Efimova E, Emerson L, Sandhu GS, Shihab F. Factors associated with nonadherence to medication in kidney transplant recipients. Nephron Clin Pract. 2011; 117(1):c33-9.
    View in: PubMed
  22. Wright S, Klausner D, Baird B, Williams ME, Steinman T, Tang H, Ragasa R, Goldfarb-Rumyantzev AS. Timing of dialysis initiation and survival in ESRD. Clin J Am Soc Nephrol. 2010 Oct; 5(10):1828-35.
    View in: PubMed
  23. Goldfarb-Rumyantzev AS, Rout P. Characteristics of elderly patients with diabetes and end-stage renal disease. Semin Dial. 2010 Mar-Apr; 23(2):185-90.
    View in: PubMed
  24. Goldfarb-Rumyantzev AS, Rout P, Sandhu GS, Khattak M, Tang H, Barenbaum A. Association between social adaptability index and survival of patients with chronic kidney disease. Nephrol Dial Transplant. 2010 Nov; 25(11):3672-81.
    View in: PubMed
  25. Rout P, Sandhu GS, Khattak M, Goldfarb-Rumyantzev A. Advances in volume monitoring in dialysis patients. Minerva Urol Nefrol. 2010 Mar; 62(1):13-27.
    View in: PubMed
  26. Goldfarb-Rumyantzev AS, Naiman N. Genetic predictors of acute renal transplant rejection. Nephrol Dial Transplant. 2010 Apr; 25(4):1039-47.
    View in: PubMed
  27. Johansen KL, Zhang R, Huang Y, Chen SC, Blagg CR, Goldfarb-Rumyantzev AS, Hoy CD, Lockridge RS, Miller BW, Eggers PW, Kutner NG. Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int. 2009 Nov; 76(9):984-90.
    View in: PubMed
  28. Goldfarb-Rumyantzev AS, Chelamcharla M, Bray BE, Leypoldt JK, Lavasani I, Nelson N, Lavasani T, Baird B, Cheung AK. Volume indicators and left ventricular mass during aggressive volume management in patients on thrice-weekly hemodialysis. Nephron Clin Pract. 2009; 113(4):c270-80.
    View in: PubMed
  29. Gueye AS, Baird BC, Shihab F, Koford JK, Barenbaum AL, Leviatov A, Goldfarb-Rumyantzev AS. The role of the economic environment in kidney transplant outcomes. Clin Transplant. 2009 Sep-Oct; 23(5):643-52.
    View in: PubMed
  30. Rogers CC, Johnson SR, Mandelbrot DA, Pavlakis M, Horwedel T, Karp SJ, Egbuna O, Rodrigue JR, Chudzinski RE, Goldfarb-Rumyantzev AS, Hanto DW, Curry MP. Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients. Clin Transplant. 2009 Nov-Dec; 23(6):887-96.
    View in: PubMed
  31. Goldfarb-Rumyantzev AS, Shihab F, Emerson L, Mineau G, Schaefer C, Tang H, Hunter C, Naiman N, Smith L, Kerber R. A population-based assessment of the familial component of acute kidney allograft rejection. Nephrol Dial Transplant. 2009 Aug; 24(8):2575-83.
    View in: PubMed
  32. Goldfarb-Rumyantzev AS, Naiman N. Genetic prediction of renal transplant outcome. Curr Opin Nephrol Hypertens. 2008 Nov; 17(6):573-9.
    View in: PubMed
  33. Goldfarb-Rumyantzev AS. Lipids and cardiovascular outcome in the dialysis population. Perit Dial Int. 2008 Nov-Dec; 28(6):601-3.
    View in: PubMed
  34. Naiman N, Cheung AK, Goldfarb-Rumyantzev AS. Familiality of cardiovascular mortality in end-stage renal disease patients. Am J Nephrol. 2009; 29(3):237-43.
    View in: PubMed
  35. Pavlakis M, Goldfarb-Rumyantzev AS. Diabetes after transplantation and sirolimus: what's the connection? J Am Soc Nephrol. 2008 Jul; 19(7):1255-6.
    View in: PubMed
  36. Tang H, Chelamcharla M, Baird BC, Shihab FS, Koford JK, Goldfarb-Rumyantzev AS. Factors affecting kidney-transplant outcome in recipients with lupus nephritis. Clin Transplant. 2008 May-Jun; 22(3):263-72.
    View in: PubMed
  37. Lin RS, Horn SD, Hurdle JF, Goldfarb-Rumyantzev AS. Single and multiple time-point prediction models in kidney transplant outcomes. J Biomed Inform. 2008 Dec; 41(6):944-52.
    View in: PubMed
  38. Petersen E, Baird BC, Barenbaum LL, Leviatov A, Koford JK, Shihab F, Goldfarb-Rumyantzev AS. The impact of employment status on recipient and renal allograft survival. Clin Transplant. 2008 Jul-Aug; 22(4):428-38.
    View in: PubMed
  39. Goldfarb-Rumyantzev AS, Habib AN, Baird BC, Barenbaum LL, Cheung AK. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis. Am J Kidney Dis. 2007 Nov; 50(5):791-802.
    View in: PubMed
  40. Lee J, Clayton F, Shihab F, Goldfarb-Rumyantzev A. Successful treatment of recurrent Henoch-Schönlein purpura in a renal allograft with plasmapheresis. Am J Transplant. 2008 Jan; 8(1):228-31.
    View in: PubMed
  41. Tang H, Goldfarb-Rumyantzev AS, Hunter C, Poynton MR, Tu M, Baird B, Krikov S, Koford JK, Hurdle J. Validating prediction models of kidney transplant outcome using local data. AMIA Annu Symp Proc. 2007; 1128.
    View in: PubMed
  42. Petersen E, Baird BC, Shihab F, Koford JK, Chelamcharla M, Habib A, Gueye AS, Tang H, Goldfarb-Rumyantzev AS. The impact of recipient history of cardiovascular disease on kidney transplant outcome. ASAIO J. 2007 Sep-Oct; 53(5):601-8.
    View in: PubMed
  43. Krikov S, Khan A, Baird BC, Barenbaum LL, Leviatov A, Koford JK, Goldfarb-Rumyantzev AS. Predicting kidney transplant survival using tree-based modeling. ASAIO J. 2007 Sep-Oct; 53(5):592-600.
    View in: PubMed
  44. Chelamcharla M, Javaid B, Baird BC, Goldfarb-Rumyantzev AS. The outcome of renal transplantation among systemic lupus erythematosus patients. Nephrol Dial Transplant. 2007 Dec; 22(12):3623-30.
    View in: PubMed
  45. Naiman N, Baird BC, Isaacs RB, Koford JK, Habib AN, Wang BJ, Barenbaum LL, Goldfarb-Rumyantzev AS. Role of pre-transplant marital status in renal transplant outcome. Clin Transplant. 2007 Jan-Feb; 21(1):38-46.
    View in: PubMed
  46. Gueye AS, Chelamcharla M, Baird BC, Nguyen C, Tang H, Barenbaum AL, Koford JK, Shihab F, Goldfarb-Rumyantzev AS. The association between recipient alcohol dependency and long-term graft and recipient survival. Nephrol Dial Transplant. 2007 Mar; 22(3):891-8.
    View in: PubMed
  47. Habib AN, Baird BC, Leypoldt JK, Cheung AK, Goldfarb-Rumyantzev AS. The association of lipid levels with mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant. 2006 Oct; 21(10):2881-92.
    View in: PubMed
  48. Goldfarb-Rumyantzev AS, Smith L, Shihab FS, Baird BC, Habib AN, Lin SJ, Barenbaum LL. Role of maintenance immunosuppressive regimen in kidney transplant outcome. Clin J Am Soc Nephrol. 2006 May; 1(3):563-74.
    View in: PubMed
  49. Goldfarb-Rumyantzev AS, Cheung AK, Habib AN, Wang BJ, Lin SJ, Baird BC, Naiman N, Cannon-Albright L. A population-based assessment of the familial component of chronic kidney disease mortality. Am J Nephrol. 2006; 26(2):142-8.
    View in: PubMed
  50. Lin SJ, Koford JK, Baird BC, Habib AN, Reznik I, Chelamcharla M, Shihab FS, Goldfarb-Rumyantzev AS. The association between length of post-kidney transplant hospitalization and long-term graft and recipient survival. Clin Transplant. 2006 Mar-Apr; 20(2):245-52.
    View in: PubMed
  51. Goldfarb-Rumyantzev AS, Hurdle JF, Baird BC, Stoddard G, Wang Z, Scandling JD, Barenbaum LL, Cheung AK. The role of pre-emptive re-transplant in graft and recipient outcome. Nephrol Dial Transplant. 2006 May; 21(5):1355-64.
    View in: PubMed
  52. Goldfarb-Rumyantzev AS, Koford JK, Baird BC, Chelamcharla M, Habib AN, Wang BJ, Lin SJ, Shihab F, Isaacs RB. Role of socioeconomic status in kidney transplant outcome. Clin J Am Soc Nephrol. 2006 Mar; 1(2):313-22.
    View in: PubMed
  53. Goldfarb-Rumyantzev AS, Leypoldt JK, Nelson N, Kutner NG, Cheung AK. A crossover study of short daily haemodialysis. Nephrol Dial Transplant. 2006 Jan; 21(1):166-75.
    View in: PubMed
  54. Goldfarb-Rumyantzev AS, Hurdle JF, Scandling JD, Baird BC, Cheung AK. The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival. Am J Kidney Dis. 2005 Sep; 46(3):537-49.
    View in: PubMed
  55. Lin SJ, Koford JK, Baird BC, Hurdle JF, Krikov S, Habib AN, Goldfarb-Rumyantzev AS. Effect of donors' intravenous drug use, cigarette smoking, and alcohol dependence on kidney transplant outcome. Transplantation. 2005 Aug 27; 80(4):482-6.
    View in: PubMed
  56. Goldfarb-Rumyantzev AS, Baird BC, Leypoldt JK, Cheung AK. The association between BP and mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant. 2005 Aug; 20(8):1693-701.
    View in: PubMed
  57. Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, Baird B, Barenbaum L, Cheung AK. Duration of end-stage renal disease and kidney transplant outcome. Nephrol Dial Transplant. 2005 Jan; 20(1):167-75.
    View in: PubMed
  58. Leypoldt JK, Cheung AK, Deeter RB, Goldfarb-Rumyantzev A, Greene T, Depner TA, Kusek J. Kinetics of urea and beta-microglobulin during and after short hemodialysis treatments. Kidney Int. 2004 Oct; 66(4):1669-76.
    View in: PubMed
  59. Goldfarb-Rumyantzev AS, Scandling JD, Pappas L, Smout RJ, Horn S. Prediction of 3-yr cadaveric graft survival based on pre-transplant variables in a large national dataset. Clin Transplant. 2003 Dec; 17(6):485-97.
    View in: PubMed
  60. Goldfarb-Rumyantzev A, Schwenk MH, Liu S, Charytan C, Spinowitz BS. Prediction of single-pool Kt/v based on clinical and hemodialysis variables using multilinear regression, tree-based modeling, and artificial neural networks. Artif Organs. 2003 Jun; 27(6):544-54.
    View in: PubMed
  61. Goldfarb-Rumyantzev AS, Cheung AK, Leypoldt JK. Computer simulation of small-solute and middle-molecule removal during short daily and long thrice-weekly hemodialysis. Am J Kidney Dis. 2002 Dec; 40(6):1211-8.
    View in: PubMed
  62. Goldfarb-Rumyantzev AS, Schwenk MH, Liu S, Wrone E, Leypoldt JK. New empiric expressions to calculate single pool Kt/V and equilibriated Kt/V. ASAIO J. 2002 Sep-Oct; 48(5):570-6.
    View in: PubMed
  63. Goldfarb-Rumyantzev AS, Pappas L. Prediction of renal insufficiency in Pima Indians with nephropathy of type 2 diabetes mellitus. Am J Kidney Dis. 2002 Aug; 40(2):252-64.
    View in: PubMed
  64. Goldfarb-Rumyantzev AS, Jeyakumar A, Gumpeni R, Rubin D. Lactic acidosis associated with nucleoside analog therapy in an HIV-positive patient. AIDS Patient Care STDS. 2000 Jul; 14(7):339-42.
    View in: PubMed
  65. Charytan C, Goldfarb-Rumyantzev A, Wang YF, Schwenk MH, Spinowitz BS. Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin therapy in chronic dialysis patients. Am J Nephrol. 1998; 18(6):498-503.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Goldfarb-Rumyantzev's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_